At @ weeks , the adjusted mean change in HbA@c was greater in patients receiving dulaglutide @ mg ( -@ % -LSB- @ % CI -@ to -@ -RSB- , -@ mmol/mol -LSB- -@ to -@ -RSB- ) and dulaglutide @ mg ( -@ % -LSB- -@ to -@ -RSB- , -@ mmol/mol -LSB- -@ to -@ -RSB- ) than in those receiving glargine ( -@ % -LSB- -@ to -@ -RSB- , -@ mmol/mol -LSB- -@ to -@ -RSB- ) .